Register
Register
Register

Coremine Vitae

R&D Institute

www.coreminevitae.com/Oslo, Norway
2 profile visits

About

Coremine Vitae AS is a Norwegian health-technology SME operating at the intersection of life sciences, artificial intelligence, biomedical informatics and digital health. Our mission is to transform complex and fragmented biomedical information into structured, interoperable and actionable knowledge that supports research, innovation and evidence-based healthcare.

We combine scientific and clinical-domain expertise with AI, data science, knowledge engineering and European project-development experience. Our work supports the integration and interpretation of heterogeneous information from scientific literature, clinical trials, health records, medical imaging, molecular data, real-world evidence and other biomedical sources.

Our capabilities include:

  • AI-supported biomedical evidence evaluation, literature analysis and clinical-trial intelligence

  • Multimodal biomedical and health-data integration

  • Knowledge representation, semantic technologies and knowledge graphs

  • FAIR data management and health-data interoperability

  • Federated and privacy-preserving approaches for multi-site research

  • Definition of clinical needs, use cases, research questions and data requirements

  • Design of validation strategies, endpoints, performance indicators and evidence-generation pathways

  • Trustworthy and explainable AI, including uncertainty, provenance and human oversight

  • Ethics, data governance and responsible health-data use

  • Exploitation, sustainability and regulatory-planning support

  • Horizon Europe proposal development, scientific coordination and work-package leadership

Within collaborative projects, Coremine Vitae can contribute from the earliest concept-development stage through implementation, validation and exploitation. We help consortia connect technical development with genuine clinical and research needs, define credible evidence pathways and ensure that data, models and outputs are designed for interoperability, responsible reuse and longer-term impact.

We are particularly interested in European collaborations involving AI-enabled healthcare, personalised and precision medicine, virtual human twins, clinical decision support, multimodal and longitudinal health data, real-world evidence, cancer, neurological disorders and trustworthy digital-health technologies. We also welcome projects addressing federated research infrastructures, European health-data ecosystems and the responsible secondary use of health data.

Coremine Vitae is seeking partnerships with universities, hospitals, research organisations, technology developers, SMEs, patient organisations, public authorities and other innovation actors in Türkiye and across Europe. We are open to joining emerging Horizon Europe consortia, co-developing new project concepts and contributing our biomedical, clinical, data-integration and European project expertise to ambitious collaborative initiatives.

Cluster 4: Digital & Industry

HORIZON-CL4-2027-04-DIGITAL-EMERGING-06: International cooperation in AIHORIZON-CL4-2027-04-DIGITAL-EMERGING-10: Horizon scanning and foresight in future enabling digital technologiesHORIZON-CL4-2027-04-HUMAN-07: Facilitate the engagement of European stakeholders in international digital standardisation

Cluster 5: Mobility

HORIZON-CL5-2027-03-D5-03: Data-driven circular economy for e-mobility ecosystem (2ZERO Partnership)HORIZON-CL5-2027-03-D5-17: Innovative Solutions for mitigating the environmental impact of waterborne transport in marine and aquatic Ecosystems (ZEWT Partnership)HORIZON-CL5-2027-03-D5-20: Assessing the effect of airport operations on air quality and noise in nearby communities

Cluster 5: Energy

HORIZON-CL5-2027-02-D3-24   Large scale operational validation and upscaling of state-of-the-art (Generative) AI tools and models powering a next generation digital energy system

Cluster 1: Health

HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseasesHORIZON-HLTH-2027-02-DISEASE-14-two-stage: Clinical trials for advancing innovative interventions for neurodegenerative diseasesHORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medicationsHORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseasesHORIZON-HLTH-2027-03-TOOL-04: Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosisHORIZON-HLTH-2027-03-TOOL-08: Towards Artificial General Intelligence (AGI) for healthcare

Representatives

Chief Executive Officer

Coremine Vitae